Therefore, in order to evaluate the possible mechanisms of the anti-allodynic effects produced by SFN in type 2 diabetic mice, we measured changes in the protein levels of Nrf2, HO-1, NQO1, and JNK in the sciatic nerve from SFN treated db/db mice. This evidence concerns the gene NQO1 and type 2 diabetes mellitus.